Kyntra BioKYNB
13F holders, Q2 2026 (June 30)27holders −5
1new positions
5sold out
1famous investor
$7.55avg. 13F price*
At the end of Q2 2026, 27 institutions reported holding Kyntra Bio Inc. (KYNB) in their 13F filings, down 5 from Q1 2026. 1 opened new positions and 5 sold out. The largest holders were Armistice Capital, LLC ($3.0M), Vanguard Capital Management LLC ($1.2M) and Acadian Asset Management LLC ($795K). One famous investor held it Jim Simons / Peter Brown (0.0% of Renaissance Technologies's portfolio).
- Company
- Kyntra Bio Inc.
- CUSIP
- 31572Q881
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q1 2026 → Q2 2026
| Institutions | Total Value | |
|---|---|---|
| New Positions | 1 | $119K |
| Exits | 5 | $154K |
All 13F filers, Q1 2026 → Q2 2026: 19,989 shares bought and 55,707 shares sold, net −35,718 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 27 holders
| Armistice Capital, LLC | 0.08% | No change | 400,000 | $3.0M |
| Vanguard Capital Management LLC | 0.00% | Add +2.1% | 159,950 | $1.2M |
| Acadian Asset Management LLC | 0.00% | No change | 105,585 | $795K |
| BlackRock, Inc. | 0.00% | Reduce 0.0% | 84,330 | $637K |
| Geode Capital Management, LLC | 0.00% | Reduce -6.0% | 43,219 | $326K |
| HighTower Advisors, LLC | 0.00% | Add +0.0% | 39,746 | $300K |
| Two Sigma Investments, LP | 0.00% | Reduce -20.2% | 39,511 | $298K |
| Renaissance Technologies | 0.00% | Reduce -1.5% | 27,081 | $204K |
| Vanguard Fiduciary Trust Co. | 0.00% | Add +0.7% | 24,105 | $182K |
| Birchview Capital, LP | 0.08% | No change | 22,566 | $170K |
| State Street Corp. | 0.00% | No change | 20,284 | $153K |
| Gsa Capital Partners LLP | 0.01% | New | 15,697 | $119K |
| UBS Group AG | 0.00% | Reduce -71.5% | 7,857 | $59K |
| Group One Trading LLC | 0.00% | Reduce -1.9% | 4,406 | $33K |
| Vanguard Global Advisers, LLC | 0.00% | No change | 1,424 | $11K |
| Tower Research Capital LLC (TRC) | 0.00% | Add +235.2% | 1,113 | $8K |
| Axiom Investment Management LLC | 0.00% | No change | 704 | $5K |
| Morgan Stanley | 0.00% | Reduce -0.2% | 487 | $4K |
| Harbour Investments, Inc. | 0.00% | No change | 200 | $2K |
| National Bank of Canada | 0.00% | No change | 193 | $1K |
| Osaic Holdings, Inc. | 0.00% | Add +1.1% | 182 | $1K |
| SBI Securities Co., Ltd. | 0.00% | No change | 152 | $1K |
| Royal Bank of Canada | 0.00% | Add +0.7% | 138 | $1K |
| BNP Paribas Financial Markets | 0.00% | Reduce -8.0% | 46 | $347 |
| JPMorgan Chase & Co. | 0.00% | No change | 12 | $88 |
| Danske Bank A/S | 0.00% | No change | 1 | $8 |
| Smithfield Trust Co | 0.00% | No change | 1 | $0 |
"% of holder's portfolio" is KYNB's weight in each manager's 13F, not the share of Kyntra Bio Inc. the manager owns.